MTMR4 attenuates transforming growth factor beta (TGFbeta) signaling by dephosphorylating R-Smads in endosomes

Junjing Yu1, Lei Pan, Xincheng Qin

  • 1Key Laboratory of Infection and Immunity of the Chinese Academy of Sciences, Institute of Biophysics, Beijing 100101, China.

Insights

Myotubularin-related protein 4 (MTMR4) dephosphorylates R-Smads in early endosomes, attenuating transforming growth factor beta (TGFbeta) signaling. This phosphatase prevents overactivation of TGFbeta signaling by limiting Smad3 nuclear translocation.

Area of Science:

  • Cellular Biology
  • Molecular Signaling
  • Signal Transduction

Background:

  • Transforming growth factor beta (TGFbeta) signaling is crucial for cellular processes, regulated by Smad phosphorylation.
  • While nuclear phosphatases terminate TGFbeta signaling, cytoplasmic regulators of R-Smad phosphorylation remain largely unknown.

Purpose of the Study:

  • To investigate the role of cytoplasmic phosphatases in regulating TGFbeta signaling.
  • To identify novel regulators of R-Smad phosphorylation and nuclear translocation.

Main Methods:

  • Co-immunoprecipitation to assess protein interactions.
  • Overexpression and knockdown (siRNA) of myotubularin-related protein 4 (MTMR4).
  • Analysis of Smad3 phosphorylation and nuclear translocation in early endosomes.

Main Results:

  • MTMR4, a dual-specificity protein phosphatase, interacts with phosphorylated R-Smads in early endosomes.
  • MTMR4 dephosphorylates R-Smads, reducing their nuclear translocation and attenuating TGFbeta signaling.
  • MTMR4 catalytic activity is essential for its function; mutations or knockdown lead to sustained Smad3 activation.

Conclusions:

  • MTMR4 acts as a cytoplasmic phosphatase that negatively regulates TGFbeta signaling.
  • MTMR4 prevents TGFbeta pathway overactivation by dephosphorylating R-Smads in early endosomes.
  • MTMR4 is a key component in maintaining TGFbeta signaling homeostasis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...